AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Amlodipine And Valsartan

11 registrations across 2 African markets— 11 active

Markets with Amlodipine And Valsartan

Recent registrations

Brand / ProductMarketHolderStatusExpires
Extor Tablets 10+160
Film-Coated Tablet
🇰🇪KenyaTHE SEARLE COMPANY LIMITEDactiveFeb 2029
Dowtor Tablets 5mg + 80mg
Tablet
🇰🇪KenyaMARTIN DOW LIMITEDactiveMar 2028
Dowtor Tablets 10mg + 160mg
Tablet
🇰🇪KenyaMARTIND DOW LIMITEDactiveMar 2028
Dowtor Tablets 5mg + 160mg
Tablet
🇰🇪KenyaMARTIN DOW LIMITEDactiveMar 2028
Exforge
Film Coated Tablet
🇹🇿TanzaniaNVS Kenya Limitedactive
zyforge 10/160
Tablets
🇹🇿TanzaniaCadila Healthcare Limitedactive
LASTAVIN AM 10/160
Film Coated Tablet
🇹🇿TanzaniaAjanta Pharma Limitedactive
ZYFORGE 5/80
Tablets
🇹🇿TanzaniaZydus Lifesciences Limitedactive
COMBISAR 10/160
Tablet, Film-coated
🇹🇿TanzaniaBilim Ilac San. ve Tic. A.Sactive
COMBISAR 5/160
Film Coated Tablet
🇹🇿TanzaniaBilim Ilac San. ve Tic. A.Sactive
Exforge
Tablets
🇹🇿TanzaniaNVS Kenya Limitedactive

Amlodipine And Valsartan in Africa — Regulatory Overview

Amlodipine And Valsartan is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Kenya. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.